Clinical trial
Effects of a Group Versus Individual Cognitive Training Program on Chemotherapy-induced Cognitive Impairment (Chemobrain) in Breast Cancer Patients Undergoing Active Treatment
NCT07165912 is registered in ClinicalTrials.gov with University of Salamanca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of a Group Versus Individual Cognitive Training Program on Chemotherapy-induced Cognitive Impairment (Chemobrain) in Breast Cancer Patients Undergoing Active Treatment
- Lead sponsor
- University of Salamanca
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- May 1, 2026
- Completion date
- December 31, 2026
- Enrollment
- 75 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer females, oncology